Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
Saved in:
| Title: | Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial. |
|---|---|
| Authors: | Lepretre S; Service d'Hématologie, Centre Henri Becquerel, Rouen, France., Aurran T, Mahé B, Cazin B, Tournilhac O, Maisonneuve H, Casasnovas O, Delmer A, Leblond V, Royer B, Corront B, Chevret S, Delépine R, Vaudaux S, Van Den Neste E, Béné MC, Letestu R, Cymbalista F, Feugier P |
| Source: | Blood [Blood] 2012 May 31; Vol. 119 (22), pp. 5104-10. Date of Electronic Publication: 2012 Feb 14. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 22337714 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lepretre+S%22">Lepretre S</searchLink>; Service d'Hématologie, Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Aurran+T%22">Aurran T</searchLink><br /><searchLink fieldCode="AU" term="%22Mahé+B%22">Mahé B</searchLink><br /><searchLink fieldCode="AU" term="%22Cazin+B%22">Cazin B</searchLink><br /><searchLink fieldCode="AU" term="%22Tournilhac+O%22">Tournilhac O</searchLink><br /><searchLink fieldCode="AU" term="%22Maisonneuve+H%22">Maisonneuve H</searchLink><br /><searchLink fieldCode="AU" term="%22Casasnovas+O%22">Casasnovas O</searchLink><br /><searchLink fieldCode="AU" term="%22Delmer+A%22">Delmer A</searchLink><br /><searchLink fieldCode="AU" term="%22Leblond+V%22">Leblond V</searchLink><br /><searchLink fieldCode="AU" term="%22Royer+B%22">Royer B</searchLink><br /><searchLink fieldCode="AU" term="%22Corront+B%22">Corront B</searchLink><br /><searchLink fieldCode="AU" term="%22Chevret+S%22">Chevret S</searchLink><br /><searchLink fieldCode="AU" term="%22Delépine+R%22">Delépine R</searchLink><br /><searchLink fieldCode="AU" term="%22Vaudaux+S%22">Vaudaux S</searchLink><br /><searchLink fieldCode="AU" term="%22Van+Den+Neste+E%22">Van Den Neste E</searchLink><br /><searchLink fieldCode="AU" term="%22Béné+MC%22">Béné MC</searchLink><br /><searchLink fieldCode="AU" term="%22Letestu+R%22">Letestu R</searchLink><br /><searchLink fieldCode="AU" term="%22Cymbalista+F%22">Cymbalista F</searchLink><br /><searchLink fieldCode="AU" term="%22Feugier+P%22">Feugier P</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2012 May 31; Vol. 119 (22), pp. 5104-10. <i>Date of Electronic Publication: </i>2012 Feb 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22337714 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood-2011-07-365437 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5104 Titles: – TitleFull: Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lepretre S – PersonEntity: Name: NameFull: Aurran T – PersonEntity: Name: NameFull: Mahé B – PersonEntity: Name: NameFull: Cazin B – PersonEntity: Name: NameFull: Tournilhac O – PersonEntity: Name: NameFull: Maisonneuve H – PersonEntity: Name: NameFull: Casasnovas O – PersonEntity: Name: NameFull: Delmer A – PersonEntity: Name: NameFull: Leblond V – PersonEntity: Name: NameFull: Royer B – PersonEntity: Name: NameFull: Corront B – PersonEntity: Name: NameFull: Chevret S – PersonEntity: Name: NameFull: Delépine R – PersonEntity: Name: NameFull: Vaudaux S – PersonEntity: Name: NameFull: Van Den Neste E – PersonEntity: Name: NameFull: Béné MC – PersonEntity: Name: NameFull: Letestu R – PersonEntity: Name: NameFull: Cymbalista F – PersonEntity: Name: NameFull: Feugier P IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 05 Text: 2012 May 31 Type: published Y: 2012 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 119 – Type: issue Value: 22 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |
